Krystal Biotech (KRYS) Non-cash Items (2016 - 2020)
Krystal Biotech's (KRYS) quarterly Non-cash Items came in at $120678.0 in Q1 2020, down 98.61% year-on-year from $8.7 million in Q2 2019, and down 99.24% quarter-over-quarter from $15.9 million in Q4 2019.
Krystal Biotech (KRYS) Non-cash Items (2016 - 2020) Analysis & Trends
Krystal Biotech has disclosed Non-cash Items across 5 years of filings, most recently posting $120678.0 for Q1 2020.
- Non-cash Items for Q1 2020 came in at $120678.0, down 98.61% year-over-year; the trailing twelve-month figure through Mar 2020 was $120678.0 (down 98.61% YoY), and the FY2019 annual result was $15.9 million, up 268.64% from the prior year.
- Non-cash Items came in at $120678.0 for Q1 2020 at Krystal Biotech, down from $15.9 million in the prior quarter.
- In the past five years, Non-cash Items ranged from a high of $18.9 million in Q3 2017 to a low of $35523.0 in Q1 2018.
- The 5-year median for Non-cash Items is $1.8 million (2017), against an average of $4.6 million.
- Across the five-year window, Non-cash Items surged 24306.72% in 2019 and tumbled 98.61% in 2020, its largest moves.
- Krystal Biotech's Non-cash Items stood at $338000.0 in 2016, then surged by 268.05% to $1.2 million in 2017, then surged by 245.82% to $4.3 million in 2018, then jumped by 268.64% to $15.9 million in 2019, then slumped by 99.24% to $120678.0 in 2020.
- The last three Non-cash Items figures came in at $120678.0 (Q1 2020), $15.9 million (Q4 2019), and $133690.0 (Q3 2019), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Krystal Biotech | 10.23 Bn | 9.41 Bn | 110.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | 120,678.00 |
| Mar 31, 2020 | 120,678.00 |
| Dec 31, 2019 | 15.86 Mn |
| Dec 31, 2019 | 15.86 Mn |
| Sep 30, 2019 | 133,690.00 |
| Sep 30, 2019 | 133,690.00 |
| Jun 30, 2019 | 131,348.00 |
| Jun 30, 2019 | 131,348.00 |
| Mar 31, 2019 | 8.67 Mn |
| Mar 31, 2019 | 8.67 Mn |
| Dec 31, 2018 | 4.30 Mn |
| Dec 31, 2018 | 4.30 Mn |
| Sep 30, 2018 | 3.23 Mn |
| Sep 30, 2018 | 3.23 Mn |
| Jun 30, 2018 | 2.36 Mn |
| Jun 30, 2018 | 2.36 Mn |
| Mar 31, 2018 | 35,523.00 |
| Mar 31, 2018 | 35,523.00 |
| Dec 31, 2017 | 1.24 Mn |
| Dec 31, 2017 | 1.24 Mn |